FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Handbook of Assay Development in Drug Discovery

Lisa K. Minor
    Product form
      FORMAT: Hardback

      R 13,986.29 Price and availability exclusive to website

      YOU COULD EARN 13,986.29 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 10 - 15 Business Days
      BUY NOW PAY LATER
      From R 2,331.04 per month!
      3x monthly payments of R 4,662.09 with
      4x fortnightly payments of R 3,496.57 with
      The need to screen targets faster and more efficiently, coupled with advances in parallel and multiplex chemical synthesis, has contributed to the increasing use of multiwell assays for drug discovery. The Handbook of Assay Development in Drug Discovery is a reference that describes the complete armament of tools currently available for performing various assay techniques.Featuring contributions from assay developers in the pharmaceutical and vendor communities, the book presents descriptions of methods, laboratory guidelines and protocols used to perform such methods, specific examples of each assay system, and troubleshooting tools. The handbook describes biochemical assay classes as well as non-class specific assay development for cell-based assays. It covers a wide range of target classes—including kinases, proteases, nuclear receptors, and GPCRs—and describes currently employed methods and assay types, such as radioligand binding assays, image analysis assays, enzyme fragment complementation, and bioluminescent and fluorescent-based assays. Designed as a guide to running an assay from start to finish, the Handbook of Assay Development in Drug Discovery is an ideal bench top companion for discovery researchers, laboratory managers, academics, and other scientists involved in drug discovery screening, lead profiling, therapeutic target evaluation, and assay development and implementation in the pharmaceutical and biotechnology industries. Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.
      Format: Hardback CONTRIBUTORS: Lisa K. Minor EAN: 9781574444711 COUNTRY: United States PAGES: WEIGHT: 1020 g HEIGHT: 254 cm
      PUBLISHED BY: Taylor & Francis Inc DATE PUBLISHED: 2006-01-20 CITY: GENRE: MEDICAL / Pharmacy, SCIENCE / Chemistry / General, SCIENCE / Life Sciences / Genetics & Genomics WIDTH: 178 cm SPINE:

      Book Themes:

      Medical research, Genetics (non-medical), Pharmaceutical chemistry and technology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      The need to screen targets faster and more efficiently, coupled with advances in parallel and multiplex chemical synthesis, has contributed to the increasing use of multiwell assays for drug discovery. The Handbook of Assay Development in Drug Discovery is a reference that describes the complete armament of tools currently available for performing various assay techniques.Featuring contributions from assay developers in the pharmaceutical and vendor communities, the book presents descriptions of methods, laboratory guidelines and protocols used to perform such methods, specific examples of each assay system, and troubleshooting tools. The handbook describes biochemical assay classes as well as non-class specific assay development for cell-based assays. It covers a wide range of target classes—including kinases, proteases, nuclear receptors, and GPCRs—and describes currently employed methods and assay types, such as radioligand binding assays, image analysis assays, enzyme fragment complementation, and bioluminescent and fluorescent-based assays. Designed as a guide to running an assay from start to finish, the Handbook of Assay Development in Drug Discovery is an ideal bench top companion for discovery researchers, laboratory managers, academics, and other scientists involved in drug discovery screening, lead profiling, therapeutic target evaluation, and assay development and implementation in the pharmaceutical and biotechnology industries. Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.
      Format: Hardback CONTRIBUTORS: Lisa K. Minor EAN: 9781574444711 COUNTRY: United States PAGES: WEIGHT: 1020 g HEIGHT: 254 cm
      PUBLISHED BY: Taylor & Francis Inc DATE PUBLISHED: 2006-01-20 CITY: GENRE: MEDICAL / Pharmacy, SCIENCE / Chemistry / General, SCIENCE / Life Sciences / Genetics & Genomics WIDTH: 178 cm SPINE:

      Book Themes:

      Medical research, Genetics (non-medical), Pharmaceutical chemistry and technology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account